Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Aptevo Therapeutics Inc. - Common Stock
(NQ:
APVO
)
7.360
+0.090 (+1.24%)
Streaming Delayed Price
Updated: 3:42 PM EST, Feb 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Aptevo Therapeutics Inc. - Common Stock
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Aptevo Therapeutics Reports 3Q 2024 Financial Results and Provides a Business Update
November 07, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
October 29, 2024
Via
Benzinga
Aptevo Therapeutics and Alligator Bioscience to Present Additional Positive Interim Phase 1 Data Evaluating ALG.APV-527 Monotherapy in Multiple Solid Tumor Types, at SITC 2024
October 29, 2024
Via
ACCESSWIRE
Dow Tumbles Over 250 Points; Boeing Posts Q3 Loss
↗
October 23, 2024
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
October 23, 2024
Via
Benzinga
Phase 1b/2 "RAINIER" Frontline Acute Myeloid Leukemia (AML) Trial Initiated
August 13, 2024
Via
ACCESSWIRE
Aptevo Therapeutics Presenting at The Protein & Antibody Engineering Summit, Boston, MA
May 14, 2024
Via
ACCESSWIRE
Why Stride Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket
↗
October 23, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
October 22, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
October 21, 2024
Via
Benzinga
Why Spirit Airlines Shares Are Trading Higher By Around 44%; Here Are 20 Stocks Moving Premarket
↗
October 21, 2024
Via
Benzinga
Aptevo Therapeutics Announces Closing of $3.0 Million Offering Priced At-the-Market Under Nasdaq Rules
September 18, 2024
Via
ACCESSWIRE
Why Intel Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
↗
September 17, 2024
Via
Benzinga
Aptevo Therapeutics Announces $3.0 Million Offering Priced At-the-Market Under Nasdaq Rules
September 16, 2024
Via
ACCESSWIRE
Aptevo Therapeutics and Alligator Bioscience Announce Data from Phase 1 ALG.APV-527 Monotherapy Trial Showing 60% of Evaluable Patients Achieved Stable Disease in Solid Tumor Study
September 16, 2024
Via
ACCESSWIRE
Aptevo Therapeutics and Alligator Bioscience to Present Positive Interim Phase 1 Data Evaluating ALG.APV-527 Monotherapy in Multiple Solid Tumor Types, at ESMO Congress 2024
September 13, 2024
Via
ACCESSWIRE
APVO Stock Earnings: Aptevo Therapeutics Beats EPS for Q2 2024
↗
August 08, 2024
APVO stock results show that Aptevo Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Aptevo Therapeutics Reports 2Q 2024 Financial Results and Provides a Business Update
August 08, 2024
Via
ACCESSWIRE
Why Domino's Pizza Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
July 18, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
↗
July 18, 2024
Pre-market stock movers are worth diving into this morning and we have all of the hottest news worth checking out on Thursday!
Via
InvestorPlace
Why Chuy's Holdings Shares Are Trading Higher By 47%; Here Are 20 Stocks Moving Premarket
↗
July 18, 2024
Via
Benzinga
Why Bloom Energy Group Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
↗
July 17, 2024
Via
Benzinga
Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
↗
July 17, 2024
Via
Benzinga
Aptevo Therapeutics Announces Closing of $2.75 Million Offering
July 01, 2024
Via
ACCESSWIRE
Aptevo Therapeutics Announces $2.75 Million Offering Priced At-the-Market Under Nasdaq Rules
June 28, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
June 17, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
↗
June 17, 2024
We have all of the biggest pre-market stock movers that investors are going to want to keep an eye on for Monday morning!
Via
InvestorPlace
Aptevo Participating in the BIO International Convention
June 03, 2024
Via
ACCESSWIRE
APVO Stock Earnings: Aptevo Therapeutics Beats EPS for Q1 2024
↗
May 08, 2024
APVO stock results show that Aptevo Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Aptevo Therapeutics Reports 1Q 2024 Financial Results and Provides a Business Update
May 08, 2024
Via
ACCESSWIRE
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
